TNYATenaya Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 22637
Ticker: TNYA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-07-30
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: TNYA

Detail

Enriched 2026-08-14 20:47

Market cap: $171,199,614.16
Shares outstanding (class): 216,998,876
Shares outstanding (weighted): 224,230,012
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 70
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.tenayatherapeutics.com
Description: Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Market cap and share counts drift.

Funds holding this security

11 funds · 11 positions · $6.87M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$4.48M	0.00%	6,475,820 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.23M	0.00%	1,774,854 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$830.9K	0.01%	1,200,002 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$121.2K	0.10%	175,000 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$82.0K	0.00%	118,382 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$78.4K	0.00%	113,232 NS	FIGI
T. Rowe Price Total Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC.	—	$21.8K	0.00%	31,453 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$14.7K	0.00%	21,195 NS	FIGI
AST Small-Cap Equity Portfolio Advanced Series Trust	—	$3.3K	0.00%	4,770 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$3.0K	0.00%	4,400 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$2.2K	0.00%	3,110 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERTNYA
FIGI_COMPOSITEBBG00FPMK2S3
FIGI_SHARE_CLASSBBG00FPMK2T2
CIK0001858848
ISINUS87990A1060
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Tenaya Therapeutics is a clinical-stage biotech company developing gene therapies for cardiac diseases.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.